Seguir
Ander Abarrategi
Ander Abarrategi
Ikerbasque Researcher at CIC biomaGUNE
Dirección de correo verificada de cicbiomagune.es - Página principal
Título
Citado por
Citado por
Año
Multiwall carbon nanotube scaffolds for tissue engineering purposes
A Abarrategi, MC Gutiérrez, C Moreno-Vicente, MJ Hortigüela, V Ramos, ...
Biomaterials 29 (1), 94-102, 2008
5302008
Titanium coatings and surface modifications: toward clinically useful bioactive implants
A Civantos, E Martínez-Campos, V Ramos, C Elvira, A Gallardo, ...
ACS Biomaterials Science & Engineering 3 (7), 1245-1261, 2017
3082017
Increased vascular permeability in the bone marrow microenvironment contributes to disease progression and drug response in acute myeloid leukemia
D Passaro, A Di Tullio, A Abarrategi, K Rouault-Pierre, K Foster, ...
Cancer cell 32 (3), 324-341. e6, 2017
2302017
Osteosarcoma: cells-of-origin, cancer stem cells, and targeted therapies
A Abarrategi, J Tornin, L Martinez-Cruzado, A Hamilton, ...
Stem cells international 2016, 2016
2152016
Tissue-specific decellularization methods: rationale and strategies to achieve regenerative compounds
U Mendibil, R Ruiz-Hernandez, S Retegi-Carrion, N Garcia-Urquia, ...
International journal of molecular sciences 21 (15), 5447, 2020
1992020
Bone microenvironment signals in osteosarcoma development
A Alfranca, L Martinez-Cruzado, J Tornin, A Abarrategi, T Amaral, ...
Cellular and molecular life sciences 72, 3097-3113, 2015
1952015
Chitosan scaffolds for osteochondral tissue regeneration
A Abarrategi, Y Lópiz‐Morales, V Ramos, A Civantos, L López‐Durán, ...
Journal of Biomedical Materials Research Part A 95 (4), 1132-1141, 2010
1162010
Modeling the human bone marrow niche in mice: From host bone marrow engraftment to bioengineering approaches
A Abarrategi, SA Mian, D Passaro, K Rouault-Pierre, W Grey, D Bonnet
Journal of Experimental Medicine 215 (3), 729-743, 2018
1132018
Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells
R Rubio, A Abarrategi, J Garcia‐Castro, L Martinez‐Cruzado, C Suarez, ...
Stem cells 32 (5), 1136-1148, 2014
1082014
Biological Properties of Solid Free Form Designed Ceramic Scaffolds with BMP-2: In Vitro and In Vivo Evaluation
A Abarrategi, C Moreno-Vicente, FJ Martínez-Vázquez, A Civantos, ...
PloS one 7 (3), e34117, 2012
1042012
Versatile humanized niche model enables study of normal and malignant human hematopoiesis
A Abarrategi, K Foster, A Hamilton, SA Mian, D Passaro, J Gribben, ...
The Journal of clinical investigation 127 (2), 543-548, 2017
952017
Cancer stem cells and cisplatin‐resistant cells isolated from non‐small‐lung cancer cell lines constitute related cell populations
BD Lopez‐Ayllon, V Moncho‐Amor, A Abarrategi, II de Cáceres, ...
Cancer medicine 3 (5), 1099-1111, 2014
872014
Chitosan film as rhBMP2 carrier: delivery properties for bone tissue application
A Abarrategi, A Civantos, V Ramos, JV Sanz Casado, JL López-Lacomba
Biomacromolecules 9 (2), 711-718, 2008
802008
In vivo comparison of the effects of rhBMP-2 and rhBMP-4 in osteochondral tissue regeneration
Y Lópiz-Morales, A Abarrategi, V Ramos, C Moreno-Vicente, ...
Eur Cell Mater 20 (367), e78, 2010
732010
Improvement of porous β-TCP scaffolds with rhBMP-2 chitosan carrier film for bone tissue application
A Abarrategi, C Moreno-Vicente, V Ramos, I Aranaz, JV Sanz Casado, ...
Tissue Engineering Part A 14 (8), 1305-1319, 2008
712008
Adipose-derived stem cells and platelet-rich plasma for preventive treatment of bisphosphonate-related osteonecrosis of the jaw in a murine model
P Barba-Recreo, T Georgiev-Hristov, ER Bravo-Burguillos, A Abarrategi, ...
Journal of Cranio-Maxillofacial Surgery 43 (7), 1161-1168, 2015
602015
Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia
A Waclawiczek, A Hamilton, K Rouault-Pierre, A Abarrategi, MG Albornoz, ...
The Journal of clinical investigation 130 (6), 3038-3050, 2020
572020
Use of rhBMP-2 activated chitosan films to improve osseointegration
JL Lopez-Lacomba, JM Garcia-Cantalejo, JV Sanz Casado, A Abarrategi, ...
Biomacromolecules 7 (3), 792-798, 2006
562006
The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia
A Di Tullio, K Rouault-Pierre, A Abarrategi, S Mian, W Grey, J Gribben, ...
Nature communications 8 (1), 1679, 2017
522017
Clonal dynamics in osteosarcoma defined by RGB marking
S Gambera, A Abarrategi, F González-Camacho, Á Morales-Molina, ...
Nature communications 9 (1), 3994, 2018
442018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20